Goldman Sachs’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $355K | Buy |
308,678
+222,376
| +258% | +$256K | ﹤0.01% | 4441 |
|
|
2025
Q1 | $129K | Buy |
86,302
+22,727
| +36% | +$33.9K | ﹤0.01% | 4772 |
|
|
2024
Q4 | $52K | Buy |
+63,575
| New | +$52K | ﹤0.01% | 4852 |
|
|
2022
Q1 | – | Sell |
-24,540
| Closed | -$132K | – | 5831 |
|
|
2021
Q4 | $132K | Buy |
+24,540
| New | +$132K | ﹤0.01% | 5137 |
|